Clinical analysis for young female patients with breast cancer

Chinese Journal of Clinical Oncology

Volumn 33, Issue 22, 2006, Pages 1316-1320

  Meng, Jie ^a   Zhang, Jin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; Clinical analysis; Young patient

Indexed keywords

EID: 79957878041     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (24)

1. Curigliano G, Rigo R, Colleoni M, et al. Adjuvant therapy for very young women with breast cancer: response according to biologic and endocrine features[J]. Clin Breast Cancer, 2004, 5(2): 125-130
2. Sidoni A, Cavaliere A, Bellezza G, et al. Breast cancer in young women: clinicopathological features and biological specificity[J]. The Breast, 2003, 12(4): 247-250
3. Schemhammer E S, Holly J M, Pollak M N, et al. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk[J]. Cancer Epidemiol Biomarkers Prev, 2005, 14(3): 699-704
4. Qinghua X, Vicente V, Vince K, et al. Female' patients with breast carcinoma age 30 years and younger have a poor prognosis[J]. Cancer, 2001, 92(10): 2523-2528
5. Johnson S M, Shaw J A, Walker R A, et al. Sporadic breast cancer in young women: prevalence of loss heterozygosity at P53, BR-CA1 and BRCA2[J]. Int J Cancer, 2002, 98(2): 205-209
6. Loman N, Johannsson O, Kristoffersson V, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer[J]. Nacl Cancer Inst, 2001, 93(16): 1215-1223
7. Silvia S, Melanie L, Victoria B, et al. Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: a population-based study[J]. Int J Cancer, 2003, 106(4): 588-593
8. 2004, 26(11): 657-679
9. Foxcroft L M, Evans E B, Porter A J, et al. The diagnosis of breast cancer in women younger than 40[J]. Breast, 2004, 13(4): 297-306
10. Rapiti E, Fioretta G, Verkooijen H M, et al. Survival of young and older breast cancer patients in Geneva from 1990 to 2001[J]. Eur J Cancer, 2005, 41(10): 1446-1452
11. Foo C S, Su D, Chong C K, et al. Breast cancer in young Asian women: study on survival[J]. ANZJ Surg, 2005, 75(7): 566-572 1
12. Sundquist M, Thorstenson S, Brudin L, et al. Incidence and prognosis in early onset breast cancer[J]. Breast, 2002, 11(1): 30-35
13. 2006, 33(2): 91-92
14. 2005, 32(8): 431-434
15. Dipen M, Lavinia P, Sijan W, et al. HER-2/neu and p53 over-expression as biomarkers of breast carcinoma in women age 30 years and younger[J]. Cancer, 2005, 103(5): 900-905
16. Colleoni M, Rotmensz N, Robertson C, et al. Very young women (<35 years) with operable breast cancer: features of disease at presentation[J]. Ann Oncol, 2002, 13(2): 273-279
17. Bottini A, Berruti A, Bersiga A, et al. Relationship between tumor shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer[J]. Br J Cancer, 2001, 85(8): 1106
18. Gentile M, Bergman M, Olsen K E, et al. P53 and survival in early onset breast cancer: analysis of gene mutations, loss of het-erozygosity and protein accumulation[J]. Eur J Cancer, 1999, 35(8): 1202-1207
19. Han W, Kim S W, Park L A, et al. Young age: an independent risk factor for disease-free survival in women with operable breast cancer[J]. BMC Cancer, 2004, 4(1): 82-90
20. Zhou P, Recht A. Young age and outcome for women with early-stage invasive breast carcinoma[J]. Cancer, 2004, 101(6): 1264-1271
21. Maggard M A, Oconnell J B, Lane K E, et al. Do young breast cancer patients have worse outcomes[J]. J Surg Res, 2003, 113(1): 109-113
22. 2005, 15(5): 408-412
23. Agnese D M, Yusuf F, Wilson J L, et al. Trends in breast cancer presentation and care according to age in a single institution[J]. Am J Surg, 2004, 188(4): 437
24. Clive S, Dixon J M. The value of adjuvant treatment in young women with breast cancer[J]. Drugs, 2002, 62(1): 1-11